Added to YB: 2026-06-02
Pitch date: 2026-05-29
VENUSREM.NS [neutral]
Venus Remedies Limited
Author Info
Nine One Capital is an India-focused investment manager. We are value-conscious investors in Indian listed companies. Sign up for the newsletter.
Company Info
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology.
Market Cap
INR 17.1B
Pitch Price
N/A
Price Target
N/A
Dividend
0.78%
EV/EBITDA
11.03
P/E
16.68
EV/Sales
2.11
Sector
Pharmaceuticals
Category
turnaround
Venus Remedies: How We Underwrote It, and What FY26 Confirmed
VENUSREM.NS (holding update): Bought ~1yr ago at Rs600cr (13x PAT); now Rs1,500cr after 2.5x move. Debt-free, FY26 rev +18% w/ receivables falling, OCF Rs155cr (>EBITDA 2nd yr), Rs250cr+ cash. Re-rate driven by earnings doubling, not multiple—still <15x PAT, 9x EV/EBITDA. AMR pipeline (VRP-034, MET-X) valued at zero as free option. First dividend in 13yrs. Holding, not trimming.
Read full article (8 min)